The pharmaceutical technology landscape: A new form of technology roadmapping

被引:79
作者
Tierney, Robert [1 ]
Hermina, Wahid [2 ,3 ]
Walsh, Steven [4 ,5 ,6 ]
机构
[1] Univ Twente, NIKOS, NL-7500 AE Enschede, Netherlands
[2] Sandia Natl Labs, Microsyst RD&A Integrat, Livermore, CA 94550 USA
[3] Sandia Natl Labs, US DOE, Livermore, CA 94550 USA
[4] Univ New Mexico, Anderson Sch Management, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Anderson Sch Management, Technol Entrepreneurship Program, Albuquerque, NM 87131 USA
[6] Univ New Mexico, Anderson Sch Management, Technol Management Ctr, Albuquerque, NM 87131 USA
关键词
Constrained innovations; Creative enterprise; Nanotechnology; Microtechnology; Technology entrepreneurship; National laboratories; MEMS; Technology roadmaps; Technology landscape; Convergence; DISRUPTIVE TECHNOLOGY; OPPORTUNITIES; FRAMEWORK; INNOVATION; SCIENCE; SYSTEMS; POLICY; FUTURE; COST;
D O I
10.1016/j.techfore.2012.05.002
中图分类号
F [经济];
学科分类号
02 ;
摘要
Practitioners are finding it increasingly difficult to develop effective roadmapping efforts for many new products and innovations. We argue that this difficulty stems from the fundamental differences between many of today's innovations and earlier ones. Many current innovations are: using technology differently; more heavily constrained; forcing new business models and increasingly being shaped by drivers. Current roadmapping techniques do not translate well to this new reality. Roadmapping efforts for these innovations are increasingly failing to meet their primary goal of including technology into the strategic process of firms, regions or industries. We seek to address this concern by creating a new roadmapping technique, one we name Technology Landscaping. We build this technique by basing it upon the relevant sections and structures found in first and second generation roadmapping theories and practices. We then apply new theory and processes that are in alignment with the nature of these new products and innovations. We test our model through a case study of new pharmaceutical industry innovations. Finally, we present our new roadmapping technique. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:194 / 211
页数:18
相关论文
共 128 条
[1]  
ABERNATHY WJ, 1978, TECHNOL REV, V80, P40
[2]   Estimating the cost of new drug development: Is it really $802 million? [J].
Adams, CP ;
Brantner, VV .
HEALTH AFFAIRS, 2006, 25 (02) :420-428
[3]  
Albright R., USE ROADMAPPING GLOB
[4]   Systems biology: A disruptive biopharmaceutical research paradigm [J].
Allarakhia, Minna ;
Wensley, Anthony .
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2007, 74 (09) :1643-1660
[5]   Analyzing and organizing nanotechnology development: Application of the institutional analysis development framework to nanotechnology consortia [J].
Allarakhia, Minna ;
Walsh, Steven .
TECHNOVATION, 2012, 32 (3-4) :216-226
[6]   Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industry [J].
Allarakhia, Minna ;
Steven, Walsh .
TECHNOVATION, 2011, 31 (2-3) :105-117
[7]  
Allhoff F, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902985027
[8]  
Alt R., 2003, International Journal of Healthcare Technology and Management, V5, P296, DOI 10.1504/IJHTM.2003.004171
[9]   Application of technology roadmaps for renewable energy sector [J].
Amer, Muhammad ;
Daim, Tugrul U. .
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2010, 77 (08) :1355-1370
[10]   The future of drug discovery and development: Shifting emphasis towards personalized medicine [J].
Amir-Aslani, Arsia ;
Mangematin, Vincent .
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2010, 77 (02) :203-217